Entheon Biomedical (XCNQ:ENBI) Accounts Payable & Accrued Expense : C$0.05 Mil (As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Accounts Payable & Accrued Expense?

Entheon Biomedical's quarterly accounts payable & accrued expense increased from Aug. 2023 (C$0.04 Mil) to Nov. 2023 (C$0.09 Mil) but then declined from Nov. 2023 (C$0.09 Mil) to Feb. 2024 (C$0.05 Mil).

Entheon Biomedical's annual accounts payable & accrued expense declined from Nov. 2021 (C$0.93 Mil) to Nov. 2022 (C$0.16 Mil) and declined from Nov. 2022 (C$0.16 Mil) to Nov. 2023 (C$0.09 Mil).

Entheon Biomedical Accounts Payable & Accrued Expense Historical Data

The historical data trend for Entheon Biomedical's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Accounts Payable & Accrued Expense Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.04

0.03

0.93

0.16

0.09

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.15	0.09	0.04	0.09	0.05

Entheon Biomedical Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines